Cargando…

Glycemic Control in Chinese Patients with Type 2 Diabetes Mellitus Receiving Oral Antihyperglycemic Medication-Only or Insulin-Only Treatment: A Cross-Sectional Survey

INTRODUCTION: The primary aim of this analysis was to explore whether glycemic control (glycated hemoglobin [HbA1c] <7%) and the incidence of hypoglycemia are different between Chinese patients with type 2 diabetes mellitus (T2DM) receiving oral antihyperglycemic medication (OAM)-only or insulin-...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yun, Liu, Li, Gu, Liqun, Babineaux, Steven, Colclough, Hayley, Curtis, Bradley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4478183/
https://www.ncbi.nlm.nih.gov/pubmed/26088603
http://dx.doi.org/10.1007/s13300-015-0114-2
_version_ 1782377855459524608
author Chen, Yun
Liu, Li
Gu, Liqun
Babineaux, Steven
Colclough, Hayley
Curtis, Bradley
author_facet Chen, Yun
Liu, Li
Gu, Liqun
Babineaux, Steven
Colclough, Hayley
Curtis, Bradley
author_sort Chen, Yun
collection PubMed
description INTRODUCTION: The primary aim of this analysis was to explore whether glycemic control (glycated hemoglobin [HbA1c] <7%) and the incidence of hypoglycemia are different between Chinese patients with type 2 diabetes mellitus (T2DM) receiving oral antihyperglycemic medication (OAM)-only or insulin-only regimens. METHODS: Physicians in nine Chinese cities completed surveys (Adelphi Real World Diabetes Disease Specific Programme) from October 2011 to March 2012. Key information collected included patients’ demographic and clinical characteristics, HbA1c levels, and hypoglycemia incidence. Patients receiving OAM-only (n = 1077) or insulin-only (n = 292) regimens for ≥6 months who had most recent HbA1c results available and measured within 3 months of survey completion were included. The primary and secondary outcomes were glycemic control and the incidence of hypoglycemia. Primary (multivariate logistic regression analysis with adjustment for potential confounders) and sensitivity analyses (propensity score matching method) were performed. RESULTS: A higher proportion of patients in the insulin-only group achieved glycemic control than patients in the OAM-only group (41.8% vs 35.9%). Insulin-only treatment was associated with significantly (P = 0.013) better glycemic control than OAM-only treatment (odds ratio [95% confidence interval]: 1.48 [1.09, 2.01]). A higher proportion of patients in the insulin-only group experienced hypoglycemia (overall) than patients in the OAM-only group (33.3% vs 14.4%). Insulin-only treatment was associated with significantly (P < 0.001) increased overall hypoglycemia compared with OAM-only treatment (odds ratio [95% confidence interval]: 2.38 [1.72, 3.29]). Sensitivity analysis results were consistent with the primary analysis results. CONCLUSIONS: The results of this analysis provide important real-world information on glycemic control and hypoglycemia in Chinese patients with T2DM, which may be useful for guiding evidenced-based management. Notably, Chinese patients with T2DM receiving OAM-only had poorer glycemic control compared with those receiving insulin-only therapy, although patients receiving OAM-only were less likely to experience hypoglycemic events. The online version of this article (doi:10.1007/s13300-015-0114-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4478183
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-44781832015-06-30 Glycemic Control in Chinese Patients with Type 2 Diabetes Mellitus Receiving Oral Antihyperglycemic Medication-Only or Insulin-Only Treatment: A Cross-Sectional Survey Chen, Yun Liu, Li Gu, Liqun Babineaux, Steven Colclough, Hayley Curtis, Bradley Diabetes Ther Original Research INTRODUCTION: The primary aim of this analysis was to explore whether glycemic control (glycated hemoglobin [HbA1c] <7%) and the incidence of hypoglycemia are different between Chinese patients with type 2 diabetes mellitus (T2DM) receiving oral antihyperglycemic medication (OAM)-only or insulin-only regimens. METHODS: Physicians in nine Chinese cities completed surveys (Adelphi Real World Diabetes Disease Specific Programme) from October 2011 to March 2012. Key information collected included patients’ demographic and clinical characteristics, HbA1c levels, and hypoglycemia incidence. Patients receiving OAM-only (n = 1077) or insulin-only (n = 292) regimens for ≥6 months who had most recent HbA1c results available and measured within 3 months of survey completion were included. The primary and secondary outcomes were glycemic control and the incidence of hypoglycemia. Primary (multivariate logistic regression analysis with adjustment for potential confounders) and sensitivity analyses (propensity score matching method) were performed. RESULTS: A higher proportion of patients in the insulin-only group achieved glycemic control than patients in the OAM-only group (41.8% vs 35.9%). Insulin-only treatment was associated with significantly (P = 0.013) better glycemic control than OAM-only treatment (odds ratio [95% confidence interval]: 1.48 [1.09, 2.01]). A higher proportion of patients in the insulin-only group experienced hypoglycemia (overall) than patients in the OAM-only group (33.3% vs 14.4%). Insulin-only treatment was associated with significantly (P < 0.001) increased overall hypoglycemia compared with OAM-only treatment (odds ratio [95% confidence interval]: 2.38 [1.72, 3.29]). Sensitivity analysis results were consistent with the primary analysis results. CONCLUSIONS: The results of this analysis provide important real-world information on glycemic control and hypoglycemia in Chinese patients with T2DM, which may be useful for guiding evidenced-based management. Notably, Chinese patients with T2DM receiving OAM-only had poorer glycemic control compared with those receiving insulin-only therapy, although patients receiving OAM-only were less likely to experience hypoglycemic events. The online version of this article (doi:10.1007/s13300-015-0114-2) contains supplementary material, which is available to authorized users. Springer Healthcare 2015-06-19 2015-06 /pmc/articles/PMC4478183/ /pubmed/26088603 http://dx.doi.org/10.1007/s13300-015-0114-2 Text en © The Author(s) 2015 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Original Research
Chen, Yun
Liu, Li
Gu, Liqun
Babineaux, Steven
Colclough, Hayley
Curtis, Bradley
Glycemic Control in Chinese Patients with Type 2 Diabetes Mellitus Receiving Oral Antihyperglycemic Medication-Only or Insulin-Only Treatment: A Cross-Sectional Survey
title Glycemic Control in Chinese Patients with Type 2 Diabetes Mellitus Receiving Oral Antihyperglycemic Medication-Only or Insulin-Only Treatment: A Cross-Sectional Survey
title_full Glycemic Control in Chinese Patients with Type 2 Diabetes Mellitus Receiving Oral Antihyperglycemic Medication-Only or Insulin-Only Treatment: A Cross-Sectional Survey
title_fullStr Glycemic Control in Chinese Patients with Type 2 Diabetes Mellitus Receiving Oral Antihyperglycemic Medication-Only or Insulin-Only Treatment: A Cross-Sectional Survey
title_full_unstemmed Glycemic Control in Chinese Patients with Type 2 Diabetes Mellitus Receiving Oral Antihyperglycemic Medication-Only or Insulin-Only Treatment: A Cross-Sectional Survey
title_short Glycemic Control in Chinese Patients with Type 2 Diabetes Mellitus Receiving Oral Antihyperglycemic Medication-Only or Insulin-Only Treatment: A Cross-Sectional Survey
title_sort glycemic control in chinese patients with type 2 diabetes mellitus receiving oral antihyperglycemic medication-only or insulin-only treatment: a cross-sectional survey
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4478183/
https://www.ncbi.nlm.nih.gov/pubmed/26088603
http://dx.doi.org/10.1007/s13300-015-0114-2
work_keys_str_mv AT chenyun glycemiccontrolinchinesepatientswithtype2diabetesmellitusreceivingoralantihyperglycemicmedicationonlyorinsulinonlytreatmentacrosssectionalsurvey
AT liuli glycemiccontrolinchinesepatientswithtype2diabetesmellitusreceivingoralantihyperglycemicmedicationonlyorinsulinonlytreatmentacrosssectionalsurvey
AT guliqun glycemiccontrolinchinesepatientswithtype2diabetesmellitusreceivingoralantihyperglycemicmedicationonlyorinsulinonlytreatmentacrosssectionalsurvey
AT babineauxsteven glycemiccontrolinchinesepatientswithtype2diabetesmellitusreceivingoralantihyperglycemicmedicationonlyorinsulinonlytreatmentacrosssectionalsurvey
AT colcloughhayley glycemiccontrolinchinesepatientswithtype2diabetesmellitusreceivingoralantihyperglycemicmedicationonlyorinsulinonlytreatmentacrosssectionalsurvey
AT curtisbradley glycemiccontrolinchinesepatientswithtype2diabetesmellitusreceivingoralantihyperglycemicmedicationonlyorinsulinonlytreatmentacrosssectionalsurvey